Surgical Management

Latest stories

1d
TechCrunch
The Mobile Health Paradox: Why Data Isn’t Nearly EnoughYusuf Sherwani is CEO at Digital Therapeutics and a senior medical student at I
The Mobile Health Paradox: Why Data Isn’t Nearly Enough
TechCrunch / Posted yesterday
Yusuf Sherwani is CEO at Digital Therapeutics and a senior medical student at Imperial College London. Across most developed economies, healthcare costs are rising faster than inflation. In the U.K., the National Health Service (NHS) faces an... Read more
3d
News-Medical-Net
Robotic nephrectomy for inferior vena cava tumor thrombus shows promise in selected patientsRenal cell carcinoma can sometimes spread to the inferior vena cava (IVC), the
Robotic nephrectomy for inferior vena cava tumor thrombus shows promise in selected patients
News-Medical-Net / Posted 3 days ago
Renal cell carcinoma can sometimes spread to the inferior vena cava (IVC), the body's largest vein, posing a threat to the heart and brain. Robotic nephrectomy for inferior vena cava tumor thrombus has favorable outcomes in selected patients compared... Read more
3d
Science Daily
Removal of complex renal tumors performed safely by robotic surgery in selected patientsRenal vein surgery can often be managed with minimally invasive laparoscopic te
Removal of complex renal tumors performed safely by robotic surgery in selected patients
Science Daily / Posted 3 days ago
Renal vein surgery can often be managed with minimally invasive laparoscopic techniques, but this is not typically advisable for an IVC thrombus (a fibrous clot), which is surgically far more complex with potentially fatal complications that can... Read more
9d
Business Wire
Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development PipelineDUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB)
Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development Pipeline
Business Wire / Posted 9 days ago
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), today provides an update on its commercial and clinical development efforts with respect to its Lymphoseek® (technetium Tc 99m tilmanocept) injection, the first and only... Read more
14d
The Young Witness
Prostate cancer patients to benefit from new nurseA prostate cancer specialist nurse care coordinator has been appointed to help
Prostate cancer patients to benefit from new nurse
The Young Witness / Posted 14 days ago
A prostate cancer specialist nurse care coordinator has been appointed to help patients in the region get the help they need, including those in Young. Christine Britton is Murrumbidgee Local Health District's new prostate cancer specialist nurse... Read more

People in this news